Coherus raises $63M in follow-on

Coherus BioSciences Inc. (NASDAQ:CHRS) fell $1.38 to $18.12 on Monday after it raised $63 million through the sale of 3.5 million shares at $18 in a follow-on underwritten by Barclays. The company proposed and priced the offering Monday before market hours. Its shares had closed at $19.50 on Friday. ...